Bristol-Myers Squibb Co.

Diabetes health impact fund T1D appoints Elizabeth Mily as CEO

The FED, Inflation and The Rally | Trading Strategies (Week of July 24)

Next Phase of Pharma Growth: Generics

BridgeBio Pharma Inks Licensing Deal With Bristol Myers Squibb Worth up to $905 Million